Approval · Notice of Compliance 4584 · 1996
TRI-CYCLEN: Notice of Compliance 4584
Issued August 19, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4584
- Date
- August 19, 1996
- Company
- Ortho Pharmaceutical, Division Of Janssen-Ortho Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Oral contraceptive
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRI-CYCLEN | 02229218 | — |
| TRI-CYCLEN | 02229226 | — |
| TRI-CYCLEN | Not yet assigned | — |
Medicinal ingredients
- ETHINYL ESTRADIOL 0.035 MG per TAB
- NORGESTIMATE 0.18 MG per TAB
- NORGESTIMATE 0.215 MG per TAB
- NORGESTIMATE 0.25 MG per TAB